Postcall Staff<\/a><\/span> April 24, 2026 <\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/p>\n<\/circle><\/path><\/svg><\/div>\n<\/a><\/p>\n<\/circle><\/path><\/svg><\/div>\n<\/a><\/p>\n<\/circle><\/path><\/svg><\/div>\n<\/a><\/p>\n<\/circle><\/path><\/svg><\/div>\n<\/a><\/div>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\nGood morning, dispensers of wisdom!<\/b><\/p>\n<\/div>\n\n \ud83e\uddea When Ozempic goes global, the questions land on your counter. A Canadian online pharmacy is now offering India\u2011sourced pens to US patients<\/a> for about $280 each \u2014 a fraction of the usual $900+ price. Nobody\u2019s quite sure how the pens are getting there, and the manufacturer says it didn\u2019t supply them, while U. officials warn about buying meds online. That means you, the pharmacist, suddenly become the ultimate fact-checker, counsellor, and reality check all at once \u2014 fielding questions about safety, authenticity, and legality, while trying to keep your shelves and sanity intact. <\/p>\n<\/div>\n\nToday\u2019s issue takes 5 minutes to read<\/span>. Only got one? Here\u2019s what to know: <\/p>\n<\/div>\n\n\n\n Roflumilast linked to early side effects <\/p>\n<\/li>\n\n Red blood cells flag vascular risk in T2D <\/p>\n<\/li>\n\n Bepirovirsen shows viral suppression in Hep\u202fB <\/p>\n<\/li>\n\n Pitavastatin may target aggressive breast cancer <\/p>\n<\/li>\n\n Flu risk drops with better airflow <\/p>\n<\/li>\n\n Canada\u2019s \u201chigh in\u201d labels change food choices <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n Let\u2019s get into it. <\/p>\n<\/div>\n\n\nStaying #Up2Date <\/span>\ud83d\udea8<\/h1>\n<\/div>\n<\/div>\n\n\n1: Real-world safety signals with roflumilast<\/b>A pharmacovigilance analysis using US and Canadian adverse event databases<\/a> found roflumilast was most commonly linked to respiratory, psychiatric, and general disorders, including cough, dyspnea, tachycardia, and symptom aggravation. Many events occurred within the first 30 days of treatment, and patterns varied by sex and formulation. The findings highlight the need for early monitoring and proactive patient counselling when starting therapy. <\/p>\n<\/div>\n\n2:<\/b>\u00a0Red blood cells and cardiovascular risk in long-standing T2D<\/b>A study of 112 adults with Type 2 diabetes<\/a> found that changes in red blood cells \u2014 particularly lower miRNA\u2011210\u20113p levels \u2014 were linked to endothelial dysfunction and higher cardiovascular risk, especially in patients with longer disease duration. The results suggest that RBC\u2011based biomarkers could help identify patients at highest risk for vascular complications and guide earlier intervention. <\/p>\n<\/div>\n\nBepirovirsen shows breakthrough potential in chronic hepatitis B<\/b>In a phase 2b trial of 369 adults<\/a> with chronic hepatitis B, adding bepirovirsen \u2014 an antisense oligonucleotide \u2014 to standard antiviral therapy led to significant declines in viral markers, including surface antigen levels, compared with standard treatment alone. The effect was most pronounced in patients not previously on nucleos(t)ide therapy, suggesting this approach could move the field closer to a functional cure. Safety was consistent with expectations, and researchers say the results support further study of bepirovirsen as a potential step toward durable viral control. <\/p>\n<\/div>\n<\/div>\n\n\nWeight Loss On Lease <\/span>\ud83d\udc89<\/h1>\n<\/div>\n<\/div>\n\n\nThe tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
<\/a><\/p>\n<\/circle><\/path><\/svg><\/div>\n<\/a><\/p>\n<\/circle><\/path><\/svg><\/div>\n<\/a><\/p>\n<\/circle><\/path><\/svg><\/div>\n<\/a><\/div>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\nGood morning, dispensers of wisdom!<\/b><\/p>\n<\/div>\n\n \ud83e\uddea When Ozempic goes global, the questions land on your counter. A Canadian online pharmacy is now offering India\u2011sourced pens to US patients<\/a> for about $280 each \u2014 a fraction of the usual $900+ price. Nobody\u2019s quite sure how the pens are getting there, and the manufacturer says it didn\u2019t supply them, while U. officials warn about buying meds online. That means you, the pharmacist, suddenly become the ultimate fact-checker, counsellor, and reality check all at once \u2014 fielding questions about safety, authenticity, and legality, while trying to keep your shelves and sanity intact. <\/p>\n<\/div>\n\nToday\u2019s issue takes 5 minutes to read<\/span>. Only got one? Here\u2019s what to know: <\/p>\n<\/div>\n\n\n\n Roflumilast linked to early side effects <\/p>\n<\/li>\n\n Red blood cells flag vascular risk in T2D <\/p>\n<\/li>\n\n Bepirovirsen shows viral suppression in Hep\u202fB <\/p>\n<\/li>\n\n Pitavastatin may target aggressive breast cancer <\/p>\n<\/li>\n\n Flu risk drops with better airflow <\/p>\n<\/li>\n\n Canada\u2019s \u201chigh in\u201d labels change food choices <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n Let\u2019s get into it. <\/p>\n<\/div>\n\n\nStaying #Up2Date <\/span>\ud83d\udea8<\/h1>\n<\/div>\n<\/div>\n\n\n1: Real-world safety signals with roflumilast<\/b>A pharmacovigilance analysis using US and Canadian adverse event databases<\/a> found roflumilast was most commonly linked to respiratory, psychiatric, and general disorders, including cough, dyspnea, tachycardia, and symptom aggravation. Many events occurred within the first 30 days of treatment, and patterns varied by sex and formulation. The findings highlight the need for early monitoring and proactive patient counselling when starting therapy. <\/p>\n<\/div>\n\n2:<\/b>\u00a0Red blood cells and cardiovascular risk in long-standing T2D<\/b>A study of 112 adults with Type 2 diabetes<\/a> found that changes in red blood cells \u2014 particularly lower miRNA\u2011210\u20113p levels \u2014 were linked to endothelial dysfunction and higher cardiovascular risk, especially in patients with longer disease duration. The results suggest that RBC\u2011based biomarkers could help identify patients at highest risk for vascular complications and guide earlier intervention. <\/p>\n<\/div>\n\nBepirovirsen shows breakthrough potential in chronic hepatitis B<\/b>In a phase 2b trial of 369 adults<\/a> with chronic hepatitis B, adding bepirovirsen \u2014 an antisense oligonucleotide \u2014 to standard antiviral therapy led to significant declines in viral markers, including surface antigen levels, compared with standard treatment alone. The effect was most pronounced in patients not previously on nucleos(t)ide therapy, suggesting this approach could move the field closer to a functional cure. Safety was consistent with expectations, and researchers say the results support further study of bepirovirsen as a potential step toward durable viral control. <\/p>\n<\/div>\n<\/div>\n\n\nWeight Loss On Lease <\/span>\ud83d\udc89<\/h1>\n<\/div>\n<\/div>\n\n\nThe tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
<\/a><\/p>\n<\/circle><\/path><\/svg><\/div>\n<\/a><\/p>\n<\/circle><\/path><\/svg><\/div>\n<\/a><\/div>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\nGood morning, dispensers of wisdom!<\/b><\/p>\n<\/div>\n\n \ud83e\uddea When Ozempic goes global, the questions land on your counter. A Canadian online pharmacy is now offering India\u2011sourced pens to US patients<\/a> for about $280 each \u2014 a fraction of the usual $900+ price. Nobody\u2019s quite sure how the pens are getting there, and the manufacturer says it didn\u2019t supply them, while U. officials warn about buying meds online. That means you, the pharmacist, suddenly become the ultimate fact-checker, counsellor, and reality check all at once \u2014 fielding questions about safety, authenticity, and legality, while trying to keep your shelves and sanity intact. <\/p>\n<\/div>\n\nToday\u2019s issue takes 5 minutes to read<\/span>. Only got one? Here\u2019s what to know: <\/p>\n<\/div>\n\n\n\n Roflumilast linked to early side effects <\/p>\n<\/li>\n\n Red blood cells flag vascular risk in T2D <\/p>\n<\/li>\n\n Bepirovirsen shows viral suppression in Hep\u202fB <\/p>\n<\/li>\n\n Pitavastatin may target aggressive breast cancer <\/p>\n<\/li>\n\n Flu risk drops with better airflow <\/p>\n<\/li>\n\n Canada\u2019s \u201chigh in\u201d labels change food choices <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n Let\u2019s get into it. <\/p>\n<\/div>\n\n\nStaying #Up2Date <\/span>\ud83d\udea8<\/h1>\n<\/div>\n<\/div>\n\n\n1: Real-world safety signals with roflumilast<\/b>A pharmacovigilance analysis using US and Canadian adverse event databases<\/a> found roflumilast was most commonly linked to respiratory, psychiatric, and general disorders, including cough, dyspnea, tachycardia, and symptom aggravation. Many events occurred within the first 30 days of treatment, and patterns varied by sex and formulation. The findings highlight the need for early monitoring and proactive patient counselling when starting therapy. <\/p>\n<\/div>\n\n2:<\/b>\u00a0Red blood cells and cardiovascular risk in long-standing T2D<\/b>A study of 112 adults with Type 2 diabetes<\/a> found that changes in red blood cells \u2014 particularly lower miRNA\u2011210\u20113p levels \u2014 were linked to endothelial dysfunction and higher cardiovascular risk, especially in patients with longer disease duration. The results suggest that RBC\u2011based biomarkers could help identify patients at highest risk for vascular complications and guide earlier intervention. <\/p>\n<\/div>\n\nBepirovirsen shows breakthrough potential in chronic hepatitis B<\/b>In a phase 2b trial of 369 adults<\/a> with chronic hepatitis B, adding bepirovirsen \u2014 an antisense oligonucleotide \u2014 to standard antiviral therapy led to significant declines in viral markers, including surface antigen levels, compared with standard treatment alone. The effect was most pronounced in patients not previously on nucleos(t)ide therapy, suggesting this approach could move the field closer to a functional cure. Safety was consistent with expectations, and researchers say the results support further study of bepirovirsen as a potential step toward durable viral control. <\/p>\n<\/div>\n<\/div>\n\n\nWeight Loss On Lease <\/span>\ud83d\udc89<\/h1>\n<\/div>\n<\/div>\n\n\nThe tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
<\/a><\/p>\n<\/circle><\/path><\/svg><\/div>\n<\/a><\/div>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\nGood morning, dispensers of wisdom!<\/b><\/p>\n<\/div>\n\n \ud83e\uddea When Ozempic goes global, the questions land on your counter. A Canadian online pharmacy is now offering India\u2011sourced pens to US patients<\/a> for about $280 each \u2014 a fraction of the usual $900+ price. Nobody\u2019s quite sure how the pens are getting there, and the manufacturer says it didn\u2019t supply them, while U. officials warn about buying meds online. That means you, the pharmacist, suddenly become the ultimate fact-checker, counsellor, and reality check all at once \u2014 fielding questions about safety, authenticity, and legality, while trying to keep your shelves and sanity intact. <\/p>\n<\/div>\n\nToday\u2019s issue takes 5 minutes to read<\/span>. Only got one? Here\u2019s what to know: <\/p>\n<\/div>\n\n\n\n Roflumilast linked to early side effects <\/p>\n<\/li>\n\n Red blood cells flag vascular risk in T2D <\/p>\n<\/li>\n\n Bepirovirsen shows viral suppression in Hep\u202fB <\/p>\n<\/li>\n\n Pitavastatin may target aggressive breast cancer <\/p>\n<\/li>\n\n Flu risk drops with better airflow <\/p>\n<\/li>\n\n Canada\u2019s \u201chigh in\u201d labels change food choices <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n Let\u2019s get into it. <\/p>\n<\/div>\n\n\nStaying #Up2Date <\/span>\ud83d\udea8<\/h1>\n<\/div>\n<\/div>\n\n\n1: Real-world safety signals with roflumilast<\/b>A pharmacovigilance analysis using US and Canadian adverse event databases<\/a> found roflumilast was most commonly linked to respiratory, psychiatric, and general disorders, including cough, dyspnea, tachycardia, and symptom aggravation. Many events occurred within the first 30 days of treatment, and patterns varied by sex and formulation. The findings highlight the need for early monitoring and proactive patient counselling when starting therapy. <\/p>\n<\/div>\n\n2:<\/b>\u00a0Red blood cells and cardiovascular risk in long-standing T2D<\/b>A study of 112 adults with Type 2 diabetes<\/a> found that changes in red blood cells \u2014 particularly lower miRNA\u2011210\u20113p levels \u2014 were linked to endothelial dysfunction and higher cardiovascular risk, especially in patients with longer disease duration. The results suggest that RBC\u2011based biomarkers could help identify patients at highest risk for vascular complications and guide earlier intervention. <\/p>\n<\/div>\n\nBepirovirsen shows breakthrough potential in chronic hepatitis B<\/b>In a phase 2b trial of 369 adults<\/a> with chronic hepatitis B, adding bepirovirsen \u2014 an antisense oligonucleotide \u2014 to standard antiviral therapy led to significant declines in viral markers, including surface antigen levels, compared with standard treatment alone. The effect was most pronounced in patients not previously on nucleos(t)ide therapy, suggesting this approach could move the field closer to a functional cure. Safety was consistent with expectations, and researchers say the results support further study of bepirovirsen as a potential step toward durable viral control. <\/p>\n<\/div>\n<\/div>\n\n\nWeight Loss On Lease <\/span>\ud83d\udc89<\/h1>\n<\/div>\n<\/div>\n\n\nThe tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
<\/a><\/div>\n<\/div>\n<\/div>\n
Good morning, dispensers of wisdom!<\/b><\/p>\n<\/div>\n\n \ud83e\uddea When Ozempic goes global, the questions land on your counter. A Canadian online pharmacy is now offering India\u2011sourced pens to US patients<\/a> for about $280 each \u2014 a fraction of the usual $900+ price. Nobody\u2019s quite sure how the pens are getting there, and the manufacturer says it didn\u2019t supply them, while U. officials warn about buying meds online. That means you, the pharmacist, suddenly become the ultimate fact-checker, counsellor, and reality check all at once \u2014 fielding questions about safety, authenticity, and legality, while trying to keep your shelves and sanity intact. <\/p>\n<\/div>\n\nToday\u2019s issue takes 5 minutes to read<\/span>. Only got one? Here\u2019s what to know: <\/p>\n<\/div>\n\n\n\n Roflumilast linked to early side effects <\/p>\n<\/li>\n\n Red blood cells flag vascular risk in T2D <\/p>\n<\/li>\n\n Bepirovirsen shows viral suppression in Hep\u202fB <\/p>\n<\/li>\n\n Pitavastatin may target aggressive breast cancer <\/p>\n<\/li>\n\n Flu risk drops with better airflow <\/p>\n<\/li>\n\n Canada\u2019s \u201chigh in\u201d labels change food choices <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n Let\u2019s get into it. <\/p>\n<\/div>\n\n\nStaying #Up2Date <\/span>\ud83d\udea8<\/h1>\n<\/div>\n<\/div>\n\n\n1: Real-world safety signals with roflumilast<\/b>A pharmacovigilance analysis using US and Canadian adverse event databases<\/a> found roflumilast was most commonly linked to respiratory, psychiatric, and general disorders, including cough, dyspnea, tachycardia, and symptom aggravation. Many events occurred within the first 30 days of treatment, and patterns varied by sex and formulation. The findings highlight the need for early monitoring and proactive patient counselling when starting therapy. <\/p>\n<\/div>\n\n2:<\/b>\u00a0Red blood cells and cardiovascular risk in long-standing T2D<\/b>A study of 112 adults with Type 2 diabetes<\/a> found that changes in red blood cells \u2014 particularly lower miRNA\u2011210\u20113p levels \u2014 were linked to endothelial dysfunction and higher cardiovascular risk, especially in patients with longer disease duration. The results suggest that RBC\u2011based biomarkers could help identify patients at highest risk for vascular complications and guide earlier intervention. <\/p>\n<\/div>\n\nBepirovirsen shows breakthrough potential in chronic hepatitis B<\/b>In a phase 2b trial of 369 adults<\/a> with chronic hepatitis B, adding bepirovirsen \u2014 an antisense oligonucleotide \u2014 to standard antiviral therapy led to significant declines in viral markers, including surface antigen levels, compared with standard treatment alone. The effect was most pronounced in patients not previously on nucleos(t)ide therapy, suggesting this approach could move the field closer to a functional cure. Safety was consistent with expectations, and researchers say the results support further study of bepirovirsen as a potential step toward durable viral control. <\/p>\n<\/div>\n<\/div>\n\n\nWeight Loss On Lease <\/span>\ud83d\udc89<\/h1>\n<\/div>\n<\/div>\n\n\nThe tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
\ud83e\uddea When Ozempic goes global, the questions land on your counter. A Canadian online pharmacy is now offering India\u2011sourced pens to US patients<\/a> for about $280 each \u2014 a fraction of the usual $900+ price. Nobody\u2019s quite sure how the pens are getting there, and the manufacturer says it didn\u2019t supply them, while U. officials warn about buying meds online. That means you, the pharmacist, suddenly become the ultimate fact-checker, counsellor, and reality check all at once \u2014 fielding questions about safety, authenticity, and legality, while trying to keep your shelves and sanity intact. <\/p>\n<\/div>\n\nToday\u2019s issue takes 5 minutes to read<\/span>. Only got one? Here\u2019s what to know: <\/p>\n<\/div>\n\n\n\n Roflumilast linked to early side effects <\/p>\n<\/li>\n\n Red blood cells flag vascular risk in T2D <\/p>\n<\/li>\n\n Bepirovirsen shows viral suppression in Hep\u202fB <\/p>\n<\/li>\n\n Pitavastatin may target aggressive breast cancer <\/p>\n<\/li>\n\n Flu risk drops with better airflow <\/p>\n<\/li>\n\n Canada\u2019s \u201chigh in\u201d labels change food choices <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n Let\u2019s get into it. <\/p>\n<\/div>\n\n\nStaying #Up2Date <\/span>\ud83d\udea8<\/h1>\n<\/div>\n<\/div>\n\n\n1: Real-world safety signals with roflumilast<\/b>A pharmacovigilance analysis using US and Canadian adverse event databases<\/a> found roflumilast was most commonly linked to respiratory, psychiatric, and general disorders, including cough, dyspnea, tachycardia, and symptom aggravation. Many events occurred within the first 30 days of treatment, and patterns varied by sex and formulation. The findings highlight the need for early monitoring and proactive patient counselling when starting therapy. <\/p>\n<\/div>\n\n2:<\/b>\u00a0Red blood cells and cardiovascular risk in long-standing T2D<\/b>A study of 112 adults with Type 2 diabetes<\/a> found that changes in red blood cells \u2014 particularly lower miRNA\u2011210\u20113p levels \u2014 were linked to endothelial dysfunction and higher cardiovascular risk, especially in patients with longer disease duration. The results suggest that RBC\u2011based biomarkers could help identify patients at highest risk for vascular complications and guide earlier intervention. <\/p>\n<\/div>\n\nBepirovirsen shows breakthrough potential in chronic hepatitis B<\/b>In a phase 2b trial of 369 adults<\/a> with chronic hepatitis B, adding bepirovirsen \u2014 an antisense oligonucleotide \u2014 to standard antiviral therapy led to significant declines in viral markers, including surface antigen levels, compared with standard treatment alone. The effect was most pronounced in patients not previously on nucleos(t)ide therapy, suggesting this approach could move the field closer to a functional cure. Safety was consistent with expectations, and researchers say the results support further study of bepirovirsen as a potential step toward durable viral control. <\/p>\n<\/div>\n<\/div>\n\n\nWeight Loss On Lease <\/span>\ud83d\udc89<\/h1>\n<\/div>\n<\/div>\n\n\nThe tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
Today\u2019s issue takes 5 minutes to read<\/span>. Only got one? Here\u2019s what to know: <\/p>\n<\/div>\n\n\n\n Roflumilast linked to early side effects <\/p>\n<\/li>\n\n Red blood cells flag vascular risk in T2D <\/p>\n<\/li>\n\n Bepirovirsen shows viral suppression in Hep\u202fB <\/p>\n<\/li>\n\n Pitavastatin may target aggressive breast cancer <\/p>\n<\/li>\n\n Flu risk drops with better airflow <\/p>\n<\/li>\n\n Canada\u2019s \u201chigh in\u201d labels change food choices <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n Let\u2019s get into it. <\/p>\n<\/div>\n\n\nStaying #Up2Date <\/span>\ud83d\udea8<\/h1>\n<\/div>\n<\/div>\n\n\n1: Real-world safety signals with roflumilast<\/b>A pharmacovigilance analysis using US and Canadian adverse event databases<\/a> found roflumilast was most commonly linked to respiratory, psychiatric, and general disorders, including cough, dyspnea, tachycardia, and symptom aggravation. Many events occurred within the first 30 days of treatment, and patterns varied by sex and formulation. The findings highlight the need for early monitoring and proactive patient counselling when starting therapy. <\/p>\n<\/div>\n\n2:<\/b>\u00a0Red blood cells and cardiovascular risk in long-standing T2D<\/b>A study of 112 adults with Type 2 diabetes<\/a> found that changes in red blood cells \u2014 particularly lower miRNA\u2011210\u20113p levels \u2014 were linked to endothelial dysfunction and higher cardiovascular risk, especially in patients with longer disease duration. The results suggest that RBC\u2011based biomarkers could help identify patients at highest risk for vascular complications and guide earlier intervention. <\/p>\n<\/div>\n\nBepirovirsen shows breakthrough potential in chronic hepatitis B<\/b>In a phase 2b trial of 369 adults<\/a> with chronic hepatitis B, adding bepirovirsen \u2014 an antisense oligonucleotide \u2014 to standard antiviral therapy led to significant declines in viral markers, including surface antigen levels, compared with standard treatment alone. The effect was most pronounced in patients not previously on nucleos(t)ide therapy, suggesting this approach could move the field closer to a functional cure. Safety was consistent with expectations, and researchers say the results support further study of bepirovirsen as a potential step toward durable viral control. <\/p>\n<\/div>\n<\/div>\n\n\nWeight Loss On Lease <\/span>\ud83d\udc89<\/h1>\n<\/div>\n<\/div>\n\n\nThe tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
Roflumilast linked to early side effects <\/p>\n<\/li>\n
Red blood cells flag vascular risk in T2D <\/p>\n<\/li>\n
Bepirovirsen shows viral suppression in Hep\u202fB <\/p>\n<\/li>\n
Pitavastatin may target aggressive breast cancer <\/p>\n<\/li>\n
Flu risk drops with better airflow <\/p>\n<\/li>\n
Canada\u2019s \u201chigh in\u201d labels change food choices <\/p>\n<\/li>\n<\/ul>\n<\/div>\n
Let\u2019s get into it. <\/p>\n<\/div>\n
1: Real-world safety signals with roflumilast<\/b>A pharmacovigilance analysis using US and Canadian adverse event databases<\/a> found roflumilast was most commonly linked to respiratory, psychiatric, and general disorders, including cough, dyspnea, tachycardia, and symptom aggravation. Many events occurred within the first 30 days of treatment, and patterns varied by sex and formulation. The findings highlight the need for early monitoring and proactive patient counselling when starting therapy. <\/p>\n<\/div>\n\n2:<\/b>\u00a0Red blood cells and cardiovascular risk in long-standing T2D<\/b>A study of 112 adults with Type 2 diabetes<\/a> found that changes in red blood cells \u2014 particularly lower miRNA\u2011210\u20113p levels \u2014 were linked to endothelial dysfunction and higher cardiovascular risk, especially in patients with longer disease duration. The results suggest that RBC\u2011based biomarkers could help identify patients at highest risk for vascular complications and guide earlier intervention. <\/p>\n<\/div>\n\nBepirovirsen shows breakthrough potential in chronic hepatitis B<\/b>In a phase 2b trial of 369 adults<\/a> with chronic hepatitis B, adding bepirovirsen \u2014 an antisense oligonucleotide \u2014 to standard antiviral therapy led to significant declines in viral markers, including surface antigen levels, compared with standard treatment alone. The effect was most pronounced in patients not previously on nucleos(t)ide therapy, suggesting this approach could move the field closer to a functional cure. Safety was consistent with expectations, and researchers say the results support further study of bepirovirsen as a potential step toward durable viral control. <\/p>\n<\/div>\n<\/div>\n\n\nWeight Loss On Lease <\/span>\ud83d\udc89<\/h1>\n<\/div>\n<\/div>\n\n\nThe tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
2:<\/b>\u00a0Red blood cells and cardiovascular risk in long-standing T2D<\/b>A study of 112 adults with Type 2 diabetes<\/a> found that changes in red blood cells \u2014 particularly lower miRNA\u2011210\u20113p levels \u2014 were linked to endothelial dysfunction and higher cardiovascular risk, especially in patients with longer disease duration. The results suggest that RBC\u2011based biomarkers could help identify patients at highest risk for vascular complications and guide earlier intervention. <\/p>\n<\/div>\n\nBepirovirsen shows breakthrough potential in chronic hepatitis B<\/b>In a phase 2b trial of 369 adults<\/a> with chronic hepatitis B, adding bepirovirsen \u2014 an antisense oligonucleotide \u2014 to standard antiviral therapy led to significant declines in viral markers, including surface antigen levels, compared with standard treatment alone. The effect was most pronounced in patients not previously on nucleos(t)ide therapy, suggesting this approach could move the field closer to a functional cure. Safety was consistent with expectations, and researchers say the results support further study of bepirovirsen as a potential step toward durable viral control. <\/p>\n<\/div>\n<\/div>\n\n\nWeight Loss On Lease <\/span>\ud83d\udc89<\/h1>\n<\/div>\n<\/div>\n\n\nThe tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
Bepirovirsen shows breakthrough potential in chronic hepatitis B<\/b>In a phase 2b trial of 369 adults<\/a> with chronic hepatitis B, adding bepirovirsen \u2014 an antisense oligonucleotide \u2014 to standard antiviral therapy led to significant declines in viral markers, including surface antigen levels, compared with standard treatment alone. The effect was most pronounced in patients not previously on nucleos(t)ide therapy, suggesting this approach could move the field closer to a functional cure. Safety was consistent with expectations, and researchers say the results support further study of bepirovirsen as a potential step toward durable viral control. <\/p>\n<\/div>\n<\/div>\n\n\nWeight Loss On Lease <\/span>\ud83d\udc89<\/h1>\n<\/div>\n<\/div>\n\n\nThe tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
The tiny print in GLP-1 contracts that nobody wants to read<\/i><\/p>\n<\/div>\n\nWhat happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
What happened: <\/b>A new study from the University of Oxford found people who stopped taking weight loss drugs like Ozempic regained most of the weight within just 2 years.\u00a0 <\/p>\n<\/div>\n\nWhy it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
Why it matters: <\/b>This was no small trial. Researchers at the University of Oxford reviewed randomized trials<\/a> and observational studies of more than 6,000 adults taking GLP-1s or other weight-loss medications, and compared them with about 3,000 people enrolled in behavioural weight-management programs. After stopping treatment, participants regained about 0.4 kg\/month \u2014 roughly 4.5 kg in the first year.\u00a0 <\/p>\n<\/div>\n\n While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
While some patients may be surprised by the findings, their doctors likely aren\u2019t. One physician <\/a>compared obesity treatment to hypertension: once the drugs start working, the underlying condition doesn\u2019t just go away. GLP-1 drugs work largely by suppressing appetite. When the medication stops, that effect does too \u2014\u00a0and fast. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n\nBut: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
But: <\/b>Hunger isn\u2019t the only post-GLP-1 concern for patients. The analysis found a reversal in cardiovascular benefits<\/a>, including improvements in heart disease and high cholesterol levels. Also diabetes control, which returned to pre-treatment levels in less than 2 years. <\/p>\n<\/div>\n\n One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n\nBottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
One researcher involved in the study said semaglutide was linked to greater weight loss when paired with support, like dieticians, who could help them cope with hunger pangs. <\/p>\n<\/div>\n
Bottom line: <\/b>The research answers one question clearly: what happens after people stop GLP-1s. But it leaves many unanswered, too, like why weight returns so quickly and whether lower-dose treatments might help. For now, the information is observational, and the evidence is still evolving. <\/p>\n<\/div>\n<\/div>\n\n\nHot Off The Press<\/span><\/h1>\n<\/div>\n<\/div>\n\n\n<\/div>\n<\/div>\n\n 1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
1: \ud83e\uddea Cholesterol drugs vs. aggressive breast cancer? Recent research suggests<\/a> pitavastatin, a common statin, may target chemotherapy-resistant triple-negative breast cancer cells by suppressing stem-like tumour cells and blocking the survival protein Mcl\u20111. Early lab results show it can enhance chemo effects, offering a potential repurposing opportunity. Pharmacists should watch this space: if clinical trials confirm safety and dosing, statins could have a future beyond heart health. <\/p>\n<\/div>\n\n 2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
2: \ud83e\udda0 A surprising <\/span>flu experiment showed<\/span><\/a><\/i><\/span><\/span> that even when healthy adults spent days indoors with people sick with influenza, none of them got infected. In a controlled study, low coughing rates and well-mixed indoor air meant virus particles didn\u2019t build up to infectious levels, suggesting that simple steps like improving ventilation and reducing face-to-face exposure could sharply cut flu spread. Researchers say masks and air movement may be key tools this season, especially in crowded indoor settings.<\/span><\/p>\n<\/div>\n\n3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
3: <\/span>\ud83e\udd57 Canada\u2019s new front-of-package nutrition labels are now in force<\/a> \u2014 Health Canada\u2019s updated rules require a bold \u201chigh in\u201d symbol on pre\u2011packaged foods that exceed thresholds for saturated fat, sugars, or sodium, making it easier for consumers to spot nutrition risk at a glance. Early expert reactions suggest the prominent icons are very effective at changing purchase behaviour. <\/p>\n<\/div>\n\n4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
4: <\/span>\ud83e\udd16 ChatGPT and Claude are officially scrubbing in. OpenAI and Anthropic both announced <\/span>new health-focused tools<\/span><\/a><\/i><\/span><\/span> this month, framing their chatbots as ways to explain lab results, summarize medical records, and help patients prepare for appointments. Experts warn the tools <\/span>aren\u2019t clinically validated<\/span><\/a><\/i><\/span><\/span> and often fall outside health-privacy laws. The AI companies are stressing their bots aren\u2019t meant to replace, but that won\u2019t stop AI \u2014 and its <\/span>questionable health tech<\/span><\/a><\/i><\/span><\/span> gadgets \u2014 from entering exam rooms, whether clinicians invite it or n<\/span><\/p>\n<\/div>\n<\/div>\n\n\nShelf Watch <\/span>\ud83c\udfea<\/h1>\n<\/div>\n<\/div>\n\n\n\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
\u26a0\ufe0f Drug Shortages<\/b><\/p>\n<\/div>\n\n\n\nBicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
Bicillin\u202fL\u2011A<\/b>: Penicillin G injections still limited; alternatives may be needed. <\/p>\n<\/li>\n\nTrandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
Trandolapril 0.5\u20131\u202fmg<\/b>: ACE inhibitor; anticipated shortage, may need alternative dosing. <\/p>\n<\/li>\n\nRocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
Rocuronium Bromide Injection 10\u202fmg:<\/b> Neuromuscular blocker for anesthesia; anticipate sourcing challenges. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n\n \ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
\ud83c\udf89 Newly Approved Drugs<\/b><\/p>\n<\/div>\n\n\n\nBepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
Bepirovirsen<\/b> \u2013 Phase 2b Hep\u202fB therapy shows viral suppression. <\/p>\n<\/li>\n\nRivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
Rivaroxaban (generic)<\/b> \u2013 Expands access for anticoagulation. <\/p>\n<\/li>\n\nIndia\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
India\u2011sourced Ozempic<\/b> \u2013 Affordable US option; pharmacists field safety questions. <\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\nPostcall Picks <\/span>\u2705<\/h1>\n<\/div>\n<\/div>\n\n\n \ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
\ud83c\udf99\ufe0f Listen: to The Pharmacy Podcast Tech Trends<\/a> with Dr. Matthew Song \u2014 learn how data and automation can make your pharmacy workflow smoother, safer, and smarter. <\/p>\n<\/div>\n\n \ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
\ud83c\udf72\u00a0<\/span>Make:<\/b><\/span> this <\/span>cozy, cheesy chicken tortilla soup<\/span><\/a><\/i><\/span><\/span> \u2014 tender chicken, black beans, corn, and soft tortilla strips \u2014 for a comforting weeknight meal.<\/span><\/p>\n<\/div>\n\n \ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
\ud83c\udf34\u00a0<\/span>Visit:<\/b><\/span> a tucked-away <\/span>Caribbean island<\/span><\/a><\/i><\/span><\/span> with high-end hotels, quiet beaches, and small towns worth wandering.<\/span><\/p>\n<\/div>\n\n \ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
\ud83d\ude02\u00a0<\/span>Laugh: <\/b><\/span>at this comic many pharmacists are all too familiar with \u2014 deciphering doctor handwriting. <\/p>\n<\/div>\n\n<\/div>\n<\/div>\n<\/div>\n\n\nTaking the Pulse <\/span>\ud83e\udec0<\/h1>\n<\/div>\n<\/div>\n\n\nWe want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
We want to ask:<\/i>\u00a0 <\/p>\n<\/div>\n\n\n\nIf you could\u2026 what would you automate in your pharmacy?<\/h3>\n<\/td>\n<\/tr>\n\n\n\n\n Inventory counts \ud83d\udce6 <\/a><\/li>\n Refill calls \ud83d\udcde <\/a><\/li>\n Lab test reminders \ud83e\uddec <\/a><\/li>\n Patient counseling \u2764\ufe0f (we know you\u2019d never give this up!) <\/a><\/li>\n Other (let us know) <\/a><\/li>\n<\/ul>\n<\/div>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n\n\nRelax<\/span><\/h1>\n<\/div>\n<\/div>\n\n\nFirst clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
First clue<\/b>: Can be whipped or iced or applied to the skin <\/p>\n<\/div>\n\n
<\/div>\n